StriderDCT is Now a CDSCO-approved Clinical Research Organization (CRO)
StriderDCT is now officially registered as a Clinical Research Organization (CRO) under the Central Drugs Standard Control Organization (CDSCO)— the country’s apex regulatory body for clinical trials.
This registration serves as a powerful endorsement of our commitment to conducting ethical, high-quality, and patient-centric clinical research.
Why does CDSCO Approval matter?
Being a CDSCO-registered CRO means StriderDCT is now fully authorized to conduct phase I-IV clinical trials and clinical equivalence studies.
This validation reflects not only our operational excellence but also our commitment to patient safety, regulatory transparency, and global compliance.
As a CDSCO-approved organization, StriderDCT delivers:
- Fully compliant, decentralized, and hybrid clinical trial models
- Accelerated trial start-up and execution timelines
- Improved patient access across urban and rural India
- Support for innovative and digital-first study models
We aim to bridge the gap between cutting-edge clinical research and real-world impact by enabling sponsors to reach diverse populations without compromising on quality or compliance.
A Step Forward for India’s Clinical Research Ecosystem
India is fast emerging as a preferred destination for clinical trials. With this accreditation, StriderDCT is poised to make a meaningful contribution to a more inclusive, accessible, and technology-enabled research ecosystem.
Whether it’s eSource, eConsent, ePRO, EDC, eTMF, remote monitoring, digital patient engagement, or hybrid trial execution, we bring together innovation and regulatory compliance to reimagine what clinical trials can look like in today’s world.
Let’s Revolutionize Clinical Trials—Together
We believe this recognition marks the beginning of an exciting chapter, not just for StriderDCT, but for every Sponsor, stakeholder, and patient who dreams of a better future through research.
We invite sponsors, investigators, and collaborators to join us in reimagining clinical research for a new era.
Contact us for a decentralized clinical trial solution.
